Aging population will fuel their gains

Article Excerpt

Shares of these two medical-device makers fell recently after their latest earnings missed expectations. However, the aging baby-boom generation should spur long-term demand for their products. C.R. BARD INC. $90 (New York symbol BCR; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 86.6 million; Market cap: $7.8 billion; Price-to-sales ratio: 2.8; Dividend yield: 0.8%; TSINetwork Rating: Above Average; www.crbard.com) makes medical devices in four main areas: vascular products, such as stents and catheters (28% of 2010 sales); oncology products that detect and treat various types of cancer (27%); urology products, such as drainage and incontinence devices (26%); and surgical tools (16%). Other medical products supply the remaining 3%. The company recently agreed to settle various lawsuits related to faulty products for treating hernias. If you exclude these costs, as well as severance costs related to a recent restructuring plan, Bard would have earned $141.7 million in the three months ended June 30, 2011. That’s up 5.7% from $134.0 million a year earlier. Earnings…